Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (2201)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$536.32
Total Value
$823.79K
Shares Held After
7,150
% of Holdings
17.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
944
Price
$535.43
Total Value
$505.44K
Shares Held After
8,686
% of Holdings
9.8%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
1,703
Price
$99.71
Total Value
$169.81K
Shares Held After
65,604
% of Holdings
2.5%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,597
Price
$98.83
Total Value
$256.66K
Shares Held After
67,307
% of Holdings
3.7%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
804
Price
$97.89
Total Value
$78.70K
Shares Held After
69,904
% of Holdings
1.1%
Orchestra BioMed Holdings, Inc. (OBIO)
Hochman David P — Director
Shares
10,000
Price
$4.29
Total Value
$42.90K
Shares Held After
1,086,467
% of Holdings
0.9%
BRUKER CORP (BRKR)
Munch Mark — EXEC VP&PRES BRUKER NANO INC.
Shares
2,000
Price
$35.44
Total Value
$70.88K
Shares Held After
128,443
% of Holdings
1.5%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
6,565
Price
$21.52
Total Value
$141.28K
Shares Held After
226,804
% of Holdings
2.8%
PHIBRO ANIMAL HEALTH CORP (PAHC)
BENDHEIM JACK — Director
Shares
5,280
Price
$48.91
Total Value
$258.24K
Shares Held After
96,200
% of Holdings
5.2%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
27,229
Price
$21.52
Total Value
$585.97K
Shares Held After
581,952
% of Holdings
4.5%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Christianson Mark — Business Development Director
Shares
100
Price
$0.80
Total Value
$80.00
Shares Held After
214,283
% of Holdings
0.0%
Nutex Health Inc. (NUTX)
Montgomery Pamela W. — Chief Legal Officer-Healthcare
Shares
79
Price
$88.87
Total Value
$7.02K
Shares Held After
2,758
% of Holdings
2.9%
Senseonics Holdings, Inc. (SENS)
ROEDER DOUGLAS A — Director
Shares
17,500
Price
$5.73
Total Value
$100.28K
Shares Held After
119,731
% of Holdings
14.6%
Senseonics Holdings, Inc. (SENS)
Goodnow Timothy T — Director
Shares
17,225
Price
$5.79
Total Value
$99.73K
Shares Held After
651,243
% of Holdings
2.6%
MBX Biosciences, Inc. (MBX)
Hawryluk P. Kent — Director
Shares
18,500
Price
$28.41
Total Value
$525.66K
Shares Held After
486,777
% of Holdings
3.8%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$12.96
Total Value
$247.02K
Shares Held After
507,934
% of Holdings
3.6%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
1,410
Price
$55.23
Total Value
$77.87K
Shares Held After
7,069
% of Holdings
16.6%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
7,308
Price
$55.23
Total Value
$403.58K
Shares Held After
19,923
% of Holdings
26.8%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
1,342
Price
$55.23
Total Value
$74.11K
Shares Held After
7,301
% of Holdings
15.5%
STAAR SURGICAL CO (STAA)
BROADWOOD PARTNERS, L.P. — Director
Shares
316,017
Price
$18.61
Total Value
$5.88M
Shares Held After
16,123,842
% of Holdings
2.0%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
11,943
Price
$27.16
Total Value
$324.34K
Shares Held After
65,925
% of Holdings
15.3%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
61,253
Price
$26.17
Total Value
$1.60M
Shares Held After
77,868
% of Holdings
44.0%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
12,068
Price
$27.13
Total Value
$327.44K
Shares Held After
62,085
% of Holdings
16.3%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
107,961
Price
$26.15
Total Value
$2.82M
Shares Held After
74,153
% of Holdings
59.3%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$72.62
Total Value
$36.31K
Shares Held After
79,390
% of Holdings
0.6%
ANI PHARMACEUTICALS INC (ANIP)
Mutz Christopher — HEAD OF RARE DISEASE
Shares
3,162
Price
$71.64
Total Value
$226.53K
Shares Held After
91,309
% of Holdings
3.3%
UNIVERSAL HEALTH SERVICES INC (UHS)
SUSSMAN ELLIOT J MD MBA — Director
Shares
356
Price
$193.37
Total Value
$68.84K
Shares Held After
6,113
% of Holdings
5.5%
Indivior Pharmaceuticals, Inc. (INDV)
Ryan Barbara — Director
Shares
8
Price
$31.09
Total Value
$248.68
Shares Held After
5,724
% of Holdings
0.1%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
370,000
Price
$5.00
Total Value
$1.85M
Shares Held After
0
% of Holdings
100.0%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
100
Price
$195.32
Total Value
$19.53K
Shares Held After
2,310,772
% of Holdings
0.0%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
4,082
Price
$194.57
Total Value
$794.22K
Shares Held After
2,310,872
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
7,043
Price
$193.58
Total Value
$1.36M
Shares Held After
2,314,954
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
8,579
Price
$192.79
Total Value
$1.65M
Shares Held After
2,321,997
% of Holdings
0.4%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
9,896
Price
$191.55
Total Value
$1.90M
Shares Held After
2,330,576
% of Holdings
0.4%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
22,063
Price
$190.53
Total Value
$4.20M
Shares Held After
2,340,472
% of Holdings
0.9%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,886
Price
$189.64
Total Value
$547.31K
Shares Held After
2,362,535
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
6,451
Price
$188.52
Total Value
$1.22M
Shares Held After
2,365,421
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
5,809
Price
$187.52
Total Value
$1.09M
Shares Held After
2,371,872
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
8,091
Price
$186.75
Total Value
$1.51M
Shares Held After
2,377,681
% of Holdings
0.3%
CERUS CORP (CERS)
Jayaraman Vivek K — Chief Operating Officer
Shares
165,200
Price
$1.66
Total Value
$273.77K
Shares Held After
1,747,674
% of Holdings
8.6%
CERUS CORP (CERS)
Green Kevin Dennis — Chief Financial Officer
Shares
127,544
Price
$1.66
Total Value
$211.37K
Shares Held After
1,040,551
% of Holdings
10.9%
CERUS CORP (CERS)
Benjamin Richard J — Chief Medical Officer
Shares
101,740
Price
$1.66
Total Value
$168.60K
Shares Held After
777,361
% of Holdings
11.6%
CERUS CORP (CERS)
Greenman William Mariner — Director
Shares
447,757
Price
$1.66
Total Value
$742.02K
Shares Held After
4,998,493
% of Holdings
8.2%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,299
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,301
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
4,458,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,815
Price
$69.29
Total Value
$402.93K
Shares Held After
4,458,747
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,885
Price
$68.47
Total Value
$950.69K
Shares Held After
4,464,562
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
655,686
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,363
Price
$69.32
Total Value
$371.75K
Shares Held After
655,986
% of Holdings
0.8%
Showing 401–450 of 2201 transactions (page 9 of 45)